HealthTree

How Effective is Tab-cel for EBV+ Post-Transplant Lymphoma?

How Effective is Tab-cel for EBV+ Post-Transplant Lymphoma? image

Sharing Your Diagnosis Journey?

HealthTree User

Primary Mediastinal B-Cell Lymphoma Discussion • March 2, 2025

AI-generated title

Is anyone navigating a diagnosis of Primary Mediastinal B cell Lymphoma who doesn't mind sharing about their journey?

How Does Axi-cel Perform in the Real World for People with LBCL?

How Does Axi-cel Perform in the Real World for People with LBCL? image

Learn How You Can Volunteer with the HealthTree Regional Cure Teams

Feb 20, 2025

12:00PM - 01:00PM EST

HealthTree Foundation Founder Jenny Ahlstrom Featured on The Pulse Podcast

Find Local Support in Your Community

Iliana • Admin

Diffuse Large B Cell Lymphoma Discussion • February 18, 2025

AI-generated title

You're not alone in facing blood cancer. At HealthTree, we know how important it is to have a strong support system. That’s why we’ve created Regional Cure Teams—volunteer-led groups that connect and support patients in their own communities. Our Cure Teams are spread across the country: 🔹 Pacific 🔹 Rocky Mountain 🔹 Southwest 🔹 Midwest 🔹 Southeast 🔹 Northeast 💙 Find your team here: https://qrco.de/CureTeams

HealthTree

https://qrco.de/CureTeams

If CAR T-Cell Therapy Fails, How Effective Are Bispecific Antibodies for Large B-Cell Lymphoma?

If CAR T-Cell Therapy Fails, How Effective Are Bispecific Antibodies for Large B-Cell Lymphoma? image

Learn How you Can Volunteer with the HealthTree Regional Cure Teams

Feb 13, 2025

12:00PM - 01:00PM EST

Brentuximab Vedotin (Adcetris) Combination Now FDA-Approved for R/R LBCL Patients Ineligible for Transplant or CAR-T

Brentuximab Vedotin (Adcetris) Combination Now FDA-Approved for R/R LBCL Patients Ineligible for Transplant or CAR-T image

Comparing CRS and ICANS Among Bispecific Antibodies

Comparing CRS and ICANS Among Bispecific Antibodies image

Studying the Keto Diet's Impact on CAR T-Cells for Large B-Cell Lymphoma

Studying the Keto Diet's Impact on CAR T-Cells for Large B-Cell Lymphoma image

Bi-Monthly Blood Cancer Financial Q&A: Expert Answers to Your Treatment Costs and Support Questions

Feb 04, 2025

01:00PM - 02:00PM EST

Real-World Data Shows Improved Outcomes for Black Patients with DLBCL

Real-World Data Shows Improved Outcomes for Black Patients with DLBCL image

HealthTree Foundation Honors Leading Blood Cancer Researchers at ASH 2024 Awards Reception

An Opportunity to Take Action: Regional Cure Teams

An Opportunity to Take Action: Regional Cure Teams image

Understanding Barriers to CAR T-Cell Therapy for Blood Cancer Patients

Understanding Barriers to CAR T-Cell Therapy for Blood Cancer Patients image

Astonishing Reversal on Cancer Research Funding Freeze

Astonishing Reversal on Cancer Research Funding Freeze image

Understanding Rare CNS Involvement in Large B-Cell Lymphoma: Largest Study Yet

Understanding Rare CNS Involvement in Large B-Cell Lymphoma: Largest Study Yet image

Changes in ACA and Medicaid: What You Need to Know and How to Prepare

Changes in ACA and Medicaid: What You Need to Know and How to Prepare image

Trial Updates on Zynlonta Combinations for DLBCL

Trial Updates on Zynlonta Combinations for DLBCL image

ACA Changes and Medicaid Expansion: What Blood Cancer Patients Need to Know and How to Stay Prepared

Jan 07, 2025

01:00PM - 02:00PM EST

CAR T-Cell Therapy: Long-Term Side Effects and Patient Outcomes from ASH 2024

CAR T-Cell Therapy: Long-Term Side Effects and Patient Outcomes from ASH 2024 image

Holiday Infection Prevention Guide for Blood Cancer Patients

Holiday Infection Prevention Guide for Blood Cancer Patients image